Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007535
Filing Date
2016-08-05
Accepted
2016-08-05 15:52:30
Documents
59
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eglt-20160630x10q.htm 10-Q 1488808
2 EX-31.1 eglt-20160630ex3114e59f3.htm EX-31.1 17254
3 EX-31.2 eglt-20160630ex312211cbf.htm EX-31.2 17592
4 EX-32.1 eglt-20160630ex3213035f3.htm EX-32.1 9085
5 EX-32.2 eglt-20160630ex32273455f.htm EX-32.2 8568
  Complete submission text file 0001558370-16-007535.txt   6416036

Data Files

Seq Description Document Type Size
6 EX-101.INS eglt-20160630.xml EX-101.INS 1409731
7 EX-101.SCH eglt-20160630.xsd EX-101.SCH 45198
8 EX-101.CAL eglt-20160630_cal.xml EX-101.CAL 61354
9 EX-101.DEF eglt-20160630_def.xml EX-101.DEF 175938
10 EX-101.LAB eglt-20160630_lab.xml EX-101.LAB 476303
11 EX-101.PRE eglt-20160630_pre.xml EX-101.PRE 322568
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Egalet Corp (Filer) CIK: 0001586105 (see all company filings)

EIN.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36295 | Film No.: 161810990
SIC: 2834 Pharmaceutical Preparations